← Eichor
Study identifier: NCT07180212 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer

Condition: Bladder Cancer · Liquid Biopsy · Cystoscopy  ·  Sponsor: Tianjin Medical University Second Hospital

PhaseNA
Planned participants360
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Non-muscle-invasive bladder cancer (NMIBC) is usually treated with surgery to remove the tumor (transurethral resection of bladder tumor, or TURBT), often followed by bladder-instilled medications to reduce the chance of the cancer coming back. Even with this treatment, high-grade NMIBC can return or progress, so patients need regular check-ups, usually with cystoscopy (a camera examination of the bladder) and urine cytology. Cystoscopy is effective but invasive, can cause discomfort, and carries risks such as infection and bleeding. This makes follow-up costly and sometimes burdensome for patients. This study is testing whether a urine tumor DNA (utDNA) test - a type of "liquid biopsy" that detects cancer-related DNA changes in urine - can help guide the timing of cystoscopy for people with high-risk or very high-risk NMIBC. utDNA testing is non-invasive and has shown high accuracy in detecting bladder cancer, sometimes spotting signs of recurrence earlier than standard methods. By combining utDNA testing with cystoscopy, we hope to safely reduce the number of unnecessary cystoscopies without missing cancer recurrences. The study will evaluate whether this approach can make bladder cancer follow-up more comfortable, more precise, and more efficient.

This description comes directly from the study's public registry record.

Talk to the study team

Hailong Hu, MD  ·  +8613662096232  ·  huhailong@tmu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (8)

Xingtai People's HospitalXingtai, Hebei, ChinaRecruiting
Sun Yat-Sen Memorial Hosipital of Sun Yat-Sen UniversityGuangzhou, ChinaRecruiting
The First Affiliated Hospital of Harbin Medical UniversityHaerbin, ChinaRecruiting
The Second Affiliated Hospital of Kunming Medical UniversityKunming, ChinaRecruiting
Nanchang Second People's HospitalNanchang, ChinaRecruiting
The second hospital of Tianjin Medical UniversityTianjin, ChinaRecruiting
General Hospital of Tianjin Medical UniversityTianjin, ChinaRecruiting
Tianjin HospitalTianjin, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07180212